Waypoint Wealth Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Waypoint Wealth Counsel's LLY Position: Q3 2026 in Review
Waypoint Wealth Counsel increased its Eli Lilly (LLY) stake by 4.6% in Q3 2026, buying an estimated $17.7K and bringing the position to 339 shares worth $392K. The position accounts for 0.23% of the portfolio, ranked #76.
Waypoint Wealth Counsel first reported a position in LLY in Q2 2023 and has held it in 14 quarters since. The position peaked at $836K in Q4 2025. 3,033 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Waypoint Wealth Counsel held 339 shares of Eli Lilly worth $392K as of Q3 2026.
- Waypoint Wealth Counsel bought 15 Eli Lilly shares in Q3 2026, an estimated $17.7K.
- Eli Lilly made up 0.23% of Waypoint Wealth Counsel's portfolio in Q3 2026, its #76 holding.
- Waypoint Wealth Counsel first reported a position in Eli Lilly in Q2 2023 and has held it in 14 quarters since.
- Waypoint Wealth Counsel's Eli Lilly position peaked at $836K in Q4 2025.
- 3,033 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Waypoint Wealth Counsel's 13F filing for Q3 2026, filed 22 Oct 2026.